Open-Label Uridine for Treatment of Depressed Adolescents with Bipolar Disorder
Notes for this study:
|Number of Subjects||7|
In an open-label trial with 1g Uridine daily for 6 weeks, there was significant improvement on depressive symptoms of bipolar disorder in adolescents. Treatment was well tolerated, and manic symptoms were not assessed but did not appear to be drastically exacerbated.